Total Payments
$1,351
2023 Payments
$114.86
Companies
11
Transactions
48
Medicare Patients
331
Medicare Billing
$41,994
Payment Breakdown by Category
Other$540.00 (40.0%)
Food & Beverage$514.66 (38.1%)
Consulting$296.00 (21.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $540.00 | 14 | 40.0% |
| Food and Beverage | $514.66 | 32 | 38.1% |
| Consulting Fee | $296.00 | 2 | 21.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $540.00 | 14 | $0 (2017) |
| Pacira Pharmaceuticals Incorporated | $296.00 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $256.56 | 17 | $0 (2023) |
| Lilly USA, LLC | $78.37 | 4 | $0 (2023) |
| UCB, Inc. | $54.32 | 3 | $0 (2022) |
| PFIZER INC. | $48.40 | 3 | $0 (2023) |
| AbbVie, Inc. | $19.36 | 1 | $0 (2019) |
| DePuy Synthes Sales Inc. | $16.08 | 1 | $0 (2023) |
| Amgen Inc. | $14.05 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $13.78 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $114.86 | 6 | Lilly USA, LLC ($54.76) |
| 2022 | $110.93 | 6 | Novartis Pharmaceuticals Corporation ($55.95) |
| 2021 | $59.75 | 4 | Novartis Pharmaceuticals Corporation ($36.80) |
| 2020 | $11.27 | 1 | Novartis Pharmaceuticals Corporation ($11.27) |
| 2019 | $158.32 | 11 | Novartis Pharmaceuticals Corporation ($125.18) |
| 2018 | $45.48 | 3 | PFIZER INC. ($31.74) |
| 2017 | $850.05 | 17 | SANOFI-AVENTIS U.S. LLC ($540.00) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Immunology | ||||||
| 06/20/2023 | DePuy Synthes Sales Inc. | MONOVISC (Device) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Sports Early Intervention | ||||||
| 06/05/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/01/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Immunology | ||||||
| 02/06/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Immunology | ||||||
| 01/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: Dermatology | ||||||
| 12/05/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Immunology | ||||||
| 08/30/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Immunology | ||||||
| 07/07/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Immunology | ||||||
| 06/21/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Immunology | ||||||
| 09/20/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: IMMUNOLOGY | ||||||
| 02/18/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 08/20/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Immunology | ||||||
| 06/17/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 47 | 58 | $14,329 | $6,245 |
| 2022 | 4 | 152 | 226 | $54,288 | $21,531 |
| 2021 | 5 | 102 | 152 | $31,158 | $11,408 |
| 2020 | 2 | 30 | 49 | $9,174 | $2,811 |
Total Patients
331
Total Services
485
Medicare Billing
$41,994
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $7,020 | $3,114 | 44.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 21 | $5,943 | $2,648 | 44.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 12 | 19 | $1,366 | $482.88 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 74 | $22,083 | $9,273 | 42.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 53 | 53 | $21,879 | $8,437 | 38.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 40 | 79 | $6,051 | $2,019 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 20 | $4,275 | $1,801 | 42.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 39 | 39 | $17,370 | $6,255 | 36.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 21 | $7,129 | $2,998 | 42.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 14 | $3,308 | $1,069 | 32.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 20 | 36 | $2,808 | $939.66 | 33.5% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 17 | 42 | $543.00 | $146.00 | 26.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 18 | 18 | $8,800 | $2,692 | 30.6% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 12 | 31 | $374.00 | $118.96 | 31.8% |
About Dr. Manoj Kohli, MD
Dr. Manoj Kohli, MD is a Rheumatology healthcare provider based in Decatur, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215948146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manoj Kohli, MD has received a total of $1,351 in payments from pharmaceutical and medical device companies, with $114.86 received in 2023. These payments were reported across 48 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($540.00).
As a Medicare-enrolled provider, Kohli has provided services to 331 Medicare beneficiaries, totaling 485 services with total Medicare billing of $41,994. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Decatur, IL
- Active Since 08/09/2006
- Last Updated 11/05/2024
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1215948146
Products in Payments
- SYNVISC-ONE (Device) $540.00
- EXPAREL (Drug) $296.00
- COSENTYX (Biological) $229.20
- TALTZ (Drug) $78.37
- Cimzia (Drug) $54.32
- XELJANZ (Drug) $35.48
- COSENTYX (Drug) $27.36
- Humira (Biological) $19.36
- MONOVISC (Device) $16.08
- Prolia (Biological) $14.05
- SIMPONI ARIA (Biological) $13.78
- ORENCIA (Biological) $13.74
- INFLECTRA (Biological) $12.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Decatur
Jefrey Lieberman, Md, MD
Rheumatology — Payments: $353,561
Rheumatology $353,561
Amir Agha, Md, MD
Rheumatology — Payments: $90,918
Rheumatology $90,918
Arshad Mustafa, M.d, M.D
Rheumatology — Payments: $13,092
Rheumatology $13,092
Dr. Gary Botstein, M.d, M.D
Rheumatology — Payments: $7,376
Rheumatology $7,376
Nehemiah Tan, M.d, M.D
Rheumatology — Payments: $6,024
Rheumatology $6,024
Emily Peninger, Md, MD
Rheumatology — Payments: $3,320
Rheumatology $3,320